Third‐Generation Bruton tyrosine kinase Inhibitors for the Treatment of Monoclonal Gammopathy of Thrombotic Significance ( MGTS) is a research paper published in American Journal of Hematology (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: HL158932
National Heart, Lung, and Blood Institute
Grant: HL171911
NHLBI NIH HHS
Grant: K99 HL171911
NHLBI NIH HHS
Grant: R01 HL158932
FWCI
3.48
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords